Laparoscopic treatment of early-stage endometrial cancer: benefits of sentinel lymph node mapping and impact on lower extremity lymphedema
View abstract on PubMed
Summary
This summary is machine-generated.Sentinel lymph node (SLN) mapping significantly reduces lymphedema risk in early-stage endometrial cancer surgery compared to systematic lymph node dissection. This minimally invasive approach offers comparable accuracy with fewer complications.
Area Of Science
- Gynecologic Oncology
- Minimally Invasive Surgery
- Cancer Staging
Background
- Laparoscopic surgery is increasingly used for early-stage endometrial cancer.
- Sentinel lymph node (SLN) mapping is a technique to identify key lymph nodes for metastasis.
- Lymphatic complications, such as lymphedema, are potential morbidities of lymph node dissection.
Purpose Of The Study
- To evaluate lymphatic-specific morbidity, specifically lower extremity lymphedema.
- To compare lymphedema rates based on different nodal assessment methods in laparoscopic endometrial cancer surgery.
Main Methods
- An ambispective study included 239 patients with early-stage endometrial cancer undergoing laparoscopic staging.
- Patients were grouped by nodal assessment: hysterectomy+SLN, hysterectomy+systematic pelvic lymphadenectomy, or hysterectomy only.
- Lymphedema was assessed via a validated questionnaire post-operatively.
Main Results
- Lymphedema prevalence was 21.4% in the SLN group versus 44.6% in the systematic lymphadenectomy group (p=0.003).
- Systematic pelvic lymphadenectomy was associated with a threefold increased risk of lymphedema (OR 3.11).
- No significant associations between lymphedema and other patient or tumor characteristics were found.
Conclusions
- Sentinel lymph node (SLN) mapping significantly reduces lymphedema compared to systematic lymph node dissection in laparoscopic endometrial cancer surgery.
- SLN mapping provides a safe and effective alternative, minimizing complications while maintaining diagnostic accuracy.
- These findings support the adoption of SLN mapping in minimally invasive endometrial cancer staging.

